FNC
LLY icon

First National Corp’s Eli Lilly LLY Stock Holding History

First National Corp’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$3.32M Sell
4,028
-17
-0.4% -$12.7K 0.63% 37
2025
Q2 		$3.15M Buy
4,045
+26
+0.6% +$20.2K 0.64% 38
2025
Q1 		$3.32M Sell
4,019
-404
-9% -$336K 0.73% 30
2024
Q4 		$3.41M Buy
4,423
+73
+2% +$60.4K 0.77% 31
2024
Q3 		$3.85M Sell
4,350
-1,709
-28% -$1.54M 0.86% 30
2024
Q2 		$5.49M Sell
6,059
-914
-13% -$731K 1.31% 23
2024
Q1 		$4.06M Hold
6,973
– – 1% 28
2023
Q4 		$4.06M Sell
6,973
-355
-5% -$207K 1% 28
2023
Q3 		$3.94M Sell
7,328
-66
-0.9% -$34K 1.06% 27
2023
Q2 		$3.47M Sell
7,394
-537
-7% -$225K 0.82% 31
2023
Q1 		$2.72M Sell
7,931
-28
-0.4% -$9.44K 0.65% 34
2022
Q4 		$2.91M Sell
7,959
-28
-0.4% -$9.93K 0.72% 32
2022
Q3 		$2.58M Sell
7,987
-329
-4% -$104K 0.71% 36
2022
Q2 		$2.7M Sell
8,316
-82
-1% -$24.6K 0.71% 35
2022
Q1 		$2.4M Sell
8,398
-334
-4% -$86K 0.51% 46
2021
Q4 		$2.41M Sell
8,732
-427
-5% -$108K 0.54% 39
2021
Q3 		$2.12M Sell
9,159
-634
-6% -$156K 0.47% 42
2021
Q2 		$1.61M Buy
9,793
+388
+4% +$77.9K 0.55% 42
2021
Q1 		$1.76M Sell
9,405
-26
-0.3% -$5.09K 0.44% 45
2020
Q4 		$1.59M Sell
9,431
-344
-4% -$51.4K 0.43% 48
2020
Q3 		$2.21M Sell
9,775
-18
-0.2% -$2.79K 0.69% 30
2020
Q2 		$1.61M Sell
9,793
-68
-0.7% -$10.4K 0.55% 42
2020
Q1 		$7.83M Sell
9,861
-224
-2% -$30.8K 5.1% 2
2019
Q4 		$1.32M Sell
10,085
-142
-1% -$16.5K 0.49% 39
2019
Q3 		$1.14M Hold
10,227
– – 0.46% 42
2019
Q2 		$1.13M Sell
10,227
-382
-4% -$45K 0.47% 41
2019
Q1 		$1.38M Sell
10,609
-736
-6% -$89.5K 0.57% 34
2018
Q4 		$1.31M Buy
+11,345
New +$1.27M 0.61% 33

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

First National Corp's LLY Position: Q3 2025 in Review

First National Corp reduced its Eli Lilly (LLY) stake by 0.42% in Q3 2025, selling an estimated $12.7K and leaving 4,028 shares worth $3.32M. The position accounts for 0.63% of the portfolio, ranked #37.

First National Corp first reported a position in LLY in Q4 2018 and has held it in 28 quarters since. The position peaked at $7.83M in Q1 2020. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • First National Corp held 4,028 shares of Eli Lilly worth $3.32M as of Q3 2025.
  • First National Corp sold 17 Eli Lilly shares in Q3 2025, an estimated $12.7K.
  • Eli Lilly made up 0.63% of First National Corp's portfolio in Q3 2025, its #37 holding.
  • First National Corp first reported a position in Eli Lilly in Q4 2018 and has held it in 28 quarters since.
  • First National Corp's Eli Lilly position peaked at $7.83M in Q1 2020.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on First National Corp's 13F filing for Q3 2025, filed 28 Oct 2025.